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Abstract
The present work investigated the antioxidant properties and antihypertensive activity of 
magnesium orotate (MgOr) using various established in vitro assays, such as β-carotene 
bleaching activity, 1,1-diphenyl-2-picrylhydrazyl (DPPH), and nitric oxide scavenging activi-
ty as well as angiotensin converting enzyme (ACE) inhibitory activity. Magnesium orotate 
nanoparticles (MgOrGANPs) were prepared using the gum arabic (GA) as stabiliser coatings 
for nanoparticles through freeze-drying method. The in vitro cytoxicity of MgOrGANPs 
against human breast cancer MCF7, liver cancer HepG2, and colon cancer HT29 was investi-
gated. The nitric oxide (NO) and DPPH scavenging assays of MgOrGANPs showed a 
dose-dependent trend, while 500 and 200 µL/mL were significantly more effective than the 
other concentrations with an IC
50
 of 89.56 µg/mL and 63.22% DPPH scavenging capacity 
respectively. The exposure of human cancer cells to MgOrGANPs at 1.56 – 1,000 µg/mL 
using 3-)4,5-dimethylthiazol-2-yl(2,5-diphenyl tetrazolium bromide (MTT) inhibited the 
growth of cell lines examined in a dose-dependent manner. Hence, MgOrGANPs may have 
great potential to be applied for cancer treatments.
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Introduction
 Various free radical scavengers of respiratory 
chain and prostaglandin synthesis are produced via 
the normal bodily physiological reactions during the 
process of respiration of aerobic organisms. The 
aforementioned biological consequences can be 
provoked by free radicals damaged deoxyribonucleic 
acid (DNA) bases but their excessive usage could 
result in damage and even kill cells. This, in turn, 
inflict various diseases like cancer and diabetes melli-
tus (Halliwell, 1994). Nevertheless, several studies 
have demonstrated that even the internal defence 
system is incapable of preventing human bodily 
reaction against reactive radicals, thereby requiring 
the need for alternative antioxidants (Kumar, 2011). 
In the past decades, there has been increased attention 
in evaluating the antioxidant activity of polymeric 
nanoparticles that are used as drug delivery systems 
(Hassani et al., 2018). The emphasis is mainly related 
to antioxidant and the functioning of bio-systems due 
to the interactions between molecular oxygen and 
biomolecules in the bio-systems, which can produce 
harmful free radicals leading to metabolic perturba-
tions (Das et al., 2013). Therefore, antioxidant 
substances are mainly utilised to destroy toxic and 
harmful effects of these free radicals specifically by 
detoxifying organisms and scavenging the free 
radicals. Previous studies have confirmed the crucial 
role of food antioxidants especially those containing 
fats and oils to be protective against free radicals such 
as hydrogen peroxide and hydroxyl radical for the 
prevention of cancers and cardiovascular diseases 
(Kris-Etherton et al., 2002; Serafini et al., 2002). 
Besides, lipid peroxides generated from oxidised 
food have resulted in various diseases such as necro-
sis of epithelial tissues, stroke, and cancers. In this 
regard, synthetic antioxidants have been used for 
scavenging these radicals (Regoli et al., 2000; Ryu et 
al., 2012).
 Various polymer-drug conjugates have been 
developed from gum arabic (GA) to enhance the 
antioxidant properties and therapeutic efficacy of 
drugs. GA is the exudate polysaccharide from gum 
acacia that possesses antioxidant properties and is 
widely used as a stabiliser or emulsifier for various 
pharmaceutical preparations (Anderson and East-
wood, 1989; Cadenas and Davies, 2000). Angioten-
sin-converting-enzyme inhibitors is an enzyme-relat-
ed carboxypeptidase (ACE2) or dipeptidyl
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carboxypeptidase (EC 3.4.15.1), which could 
ameliorate patients from suffering a heart failure 
(Vickers et al., 2002; Li et al., 2004; Sarmadi et al., 
2011). Similarly, GA, which is a plant-based hydro-
colloid, has also been reported to possess antioxidant 
and antihypertensive properties. Additionally, GA is 
also a well-known non-toxic polysaccharide with a 
stabilising effect and gelling characteristics (Abd-Al-
lah et al., 2002; Ali et al., 2009). 
 Magnesium orotate (MgOr) is a complex of 
two synergic protective components: magnesium and 
orotic acid. Previous study has established the 
antihypertensive properties of MgOr (Hacht and 
Taaya, 2006). The challenge to retain the MgOr 
applications as anticancer and antioxidant has been 
resolved through the use of a natural polysaccharide, 
such as GA (Kostova et al., 2007; Kostova and 
Valcheva-Traykova, 2015). As a highly heterogene-
ous compound, GA is incorporated with about 2% of 
polypeptide, which is an active substance that 
improves the antihypertensive effect. Furthermore, 
GA could enhance the stability and solubility of 
MgOr. In a previous study, GA demonstrated cyto-
toxicity effect against HepG2 cells due to the chemi-
cal binding of galactose groups with asialoglycopro-
tein receptor (ASGRP) on the hepatocytes for liver 
cancer delivery (Dodin and Dubois, 1980; Shon et 
al., 2003; Kostova et al., 2007). 
 Therefore, the present work aimed to devel-
op a novel nanoparticle (NP) system using GA in 
order to improve the antioxidant and antihyperten-
sive properties as well as the therapeutic efficacy of 
MgOr as an active ingredient. The antioxidant and 
antihypertensive properties of MgOr nanoparticles 
coated with GA (MgOrGANPs) were also assessed.
Materials and methods
Materials
 Gum arabic polysaccharide was purchased 
from ENNASR (Sudan). RAW 264.7 cells were 
purchased from ATCC (American Type Culture 
Collection). Magnesium orotate was purchased from 
Richest (China). Angiotensin-converting enzyme, 
Trolox, hippuryl-histidyl-leucine sulphonamide, 
N-(1-naphtyl) ethylenediamine dihydrochloride, 
sodium nitrite, linoleic acid, dexamethasone, and 
Dulbecco's modified Eagle’s medium (DMEM) high 
glucose were purchased from Sigma-Aldrich (USA). 
Tween 80, quercetin, β-carotene, and α-tocopherol 
were purchased from R&M (China). The entire work 
utilised deionised water.
Preparation of magnesium orotate nanoparticles 
 The MgOrGANPs were prepared using the 
freeze-drying method with slight modifications 
(Ashwaq et al., 2017). Briefly, 0.94 g of MgOr was 
dissolved in 50 mL of deionised water in a 100 mL 
beaker and heated at 35°C under mild agitation for 20 
min at room temperature. Then, 0.75 g of GA was 
dissolved in 50 mL of deionised water. In order to 
prepare an aqueous solution of MgOr and GA, MgOr 
solution was added dropwise to the GA solution with 
vigorous stirring for 72 h. The obtained mixture was 
mixed using Ultra-thorax at room temperature. This 
pre-emulsion was further passed through a ten cycles 
high pressure homogeniser at a pressure of 1,000 bar 
for 12 cycles to obtain a uniform mixture. The result-
ing clear solution was frozen at -80°C and then 
subsequently freeze-dried for 24 h at -55°C. The 
prepared powder having uniform properties was then 
used for characterisation.
Determination of antioxidant activity and cell 
viability
DPPH scavenging activity of MgOrGANPs
 The DPPH scavenging assay is based on the 
change of purple DPPH radicals into yellow stable 
compound. This reaction has been related to the 
donating ability of the antioxidant (Barros et al., 
2007b). DPPH was prepared as a control solution by 
using 200 μL DPPH in 200 µM methanol then mixed 
with 100 µL of each sample solution (the samples 
were dissolved first in water) on a 96-well microplate 
and placed into a container protected from light. The 
mixture was homogenised by vortexing for 1 min 
before incubating for 1 h at room temperature in the 
dark. The absorbance rate of each solution was meas-
ured using a UV-Vis spectrophotometer at 517 nm. 
Trolox served as a positive control, while MgOr and 
MgOrGANPs were the test materials.
 The stock solution of Trolox (100 µg/mL 
methanol) was prepared, and serially diluted to 
obtain a standard concentrations of 50, 75, 100, 125, 
150, and 200 µg/mL. The percentage inhibition of the 
samples was calculated using Eq. 1:
 Where, Aa, Ab, and Ac = absorbance of 
sample added into the DPPH solution, absorbance 
recorded of sample without DPPH, and the absorb-
ance of the control, respectively. The IC
50
 value is the 
amount of antioxidants (MgOr and MgOrGANPs) 
needed to halve the initial DPPH concentration.
(Eq. 1)
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Nitric-oxide radical scavenging activity
The murine monocytic macrophage cell line RAW 
264.7 were purchased from ATCC (USA), and 
cultured in DMEM including 100 units/mL penicil-
lin, 100 µg/mL streptomycin, 2 mM glutamine, and 
10% foetal bovine serum (FBS); then incubated at 
37°C and 5% CO2 for 72 h.
 The RAW 264.7 cells were cultured in 
96-well tissue cultures plates (1 × 106 cells/100 mL) 
at 37°C with 5% CO
2
 for 24 h. After reaching 90% 
confluence, the RAW 264.7 cells were removed, 
trypsinised, and centrifuged at 120 g and 4°C for 10 
min. Moreover, a serial dilution of MgOr and MgOr-
GANPs (1,000 µg/mL) in medium was prepared and 
added to the well to obtain final concentrations of 
15.6, 31.25, 62.5, 125, 250, and 500 µg/mL. The cells 
were then challenged with 10 µg/mL of LPS for 20 h. 
Nitric oxide (NO) production was quantified by the 
measure of the quantity of nitrite released into the 
supernatant of macrophage cells. The Griess reagent 
[1% (w/v) sulphonamide and 0.1% (w/v) 
N-(1-naphtyl) ethylenediamine dihydrochloride in 
2.5% (v/v) phosphoric acid] was used to quantify the 
amounts of nitrite oxidised with NO in the tissue 
culture media. To summarise, 100 µL of cell culture 
fluid was mixed with 100 µL of Griess reagent into in 
a 96-well tissue culture plate. The absorbance was 
then read spectrophotometrically using a microplate 
reader at 540 nm. Various concentrations of sodium 
nitrite were used to prepare a standard curve for the 
determination of nitrite concentration in the sample 
(Al-Qubaisi et al., 2013; Ranneh et al., 2016).
β-carotene bleaching assay (BCRA)
 The principle of this assay is focused on the 
oxidation of linoleic acid, which leads to a decrease 
of the yellow colour of β-carotene. The linoleate 
model system was used to evaluate the antioxidant 
activities of MgOr and MgOrGANPs. Briefly, 2 mg 
of β-carotene was dissolved into 10 mL of chloro-
form to prepare the β-carotene solution. The chloro-
form was then evaporated at 40°C using a vacuum 
rotary evaporator. After evaporation, Tween 80 (400 
mg) and linoleic acid (40 mg) were mixed then added 
to 100 mL of distilled water. The mixture was vigor-
ously shaken for 10 min. An emulsion without β-car-
otene was prepared and used as blank. After the addi-
tion of 50 µL of MgOr and MgOrGANPs at several 
concentrations and 200 µL of β-carotene emulsions 
into the 96-well plate, the mixture was incubated in 
the dark at 50°C. The absorbance was recorded at 
470 nm and 20 min intervals for a total of 100 min. 
The antioxidant activity of MgOr and MgOrGANPs 
was calculated using Eq. 2:
Where A
0
, At, A0c, and Atc = absorbance of sample at 
t = 0 and t = 100 min; and absorbance of control at t 
= 0 and t = 100 min, respectively. Various concentra-
tions of α-tocopherol were used as standards (Barros 
et al., 2007a).
Antihypertensive assay using angiotensin converting 
enzyme (ACE)
 In this analysis, the examination of in vitro 
ACE inhibition activity was performed to quantify 
the conversion of hippuryl-histidyl-leucine to hippu-
ric acid in the presence of an inhibitor enzyme. Brief-
ly, 100 µL of MgOr and MgOrGANPs were reacted 
with ACE (25 µL, pH 8.3), and the reaction was 
pre-incubated for 5 min at 37°C. To quantify the 
ACE inhibition activity, an addition of 10 µL of 
hippuryl-histidyl-leucine (3.5 Mm) to the assay 
mixture was then made followed by incubation for 
30, 60, and 90 min. In order to stop the reaction, 50 
µL of 3 mol/L HCI was added to the mixture. Ethyl 
acetate (1 mL) was added to extract the hippuric acid 
formed. Following evaporation at 120°C, the solvent 
was re-dissolved in deionised water. The quantifica-
tion of hippuric acid was performed by measuring the 
absorbance at 228 nm (Hussein et al., 2012). The 
reduction in absorbance recorded was proportional to 
the inhibition performed by the assayed inhibitor. 
The emulsion prepared without MgOr and MgOr-
GANPs served as control.
Cell culture and cytotoxicity assay
 Four human cell lines were purchased from 
ATCC; human colon cancer (HT29), human liver 
cancer (HepG2), human breast cancer (MCF7), and 
normal breast cancer (MCF10a). Brielfy, 200 µL of a 
1 × 104 cells/mL suspension were seeded into each 
well of the 96-well plate. The plates were then incu-
bated for 24 h at 37°C with 5% CO
2
 to ensure attach-
ment at 70 - 80% confluency. Following incubation, 
the media was removed and the cells were treated 
with fresh media (200 µL) including MgOr and 
MgOrGANPs at various concentrations of (15.6 to 
1,000 µg/mL). The plates were then incubated with 
the compounds for 72 h at 37°C with 5% CO
2
. The 
cell viability was determined based on the MTT 
assay. After that, the media was aspirated of and the 
wells were washed three times using PBS to ensure 
that MgOr and MgOrGANPs were removed. Next, 
200 µL of fresh media was added to each well and 
replaced with 200 µL of MTT-including culture 
(Eq. 2)
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MgOrGANPs appearing to be higher than that of 
MgOr.
Figure 2. Nitric oxide radical scavenging activities of 
RAW 264.7 cell line treated with different concentra-
tions of free MgOr and MgOrGANPs.
β-carotene bleaching assay (BCRA)
 The β-carotene bleaching assay is usually 
used to evaluate the loss of yellow colour of β-caro-
tene reacting with radicals in the presence of linoleic 
acid in the emulsion. In the present work, the antioxi-
dant activities of MgOr and MgOrGANPs were 
investigated using the linoleic model system. The 
results confirmed the radical scavenging activity of 
MgOr and MgOrGANPs at various concentrations as 
shown in Figure 3. 
Figure 3. Inhibition activity (%) of free MgOr and 
MgOrGANPs at various concentrations by β-caro-
tene bleaching assay.
Antihypertensive assay using angiotensin converting 
enzyme (ACE) 
 The in vitro antihypertensive activity of MgOr 
and MgOrGANPs were evaluated by converting 
hippuryl-histidyl-leucine to hippuric acid and measuring 
the ACE-inhibitory percentage based on simple absorb-
ance measurements at 228 nm as shown in Figure 4.
medium. Then, 20 µL of MTT solution (5 µg/mL) 
made to a total of 200 µL of culture medium was 
added to each well, mixed gently and incubated for 4 
h at 37°C with 5% CO
2
. The MTT+culture medium 
was replaced with 200 µL/well of DMSO in order to 
dissolve the formazan crystals formed. The absorb-
ance was measured at 570 nm using microtiter plate. 
All experiments were performed in triplicate. The 
concentration of drug required to inhibit 50% of cell 
growth was calculated from the dose-response curves 
from each cell line and each compound (Al-Qubaisi 
et al., 2013).
Statistical analysis
 All experiments were done in triplicate. 
Statistical analysis was carried out using SPSS 16 for 
Windows. The differences among the treatment 
groups was evaluated using one-way analysis of 
variance (ANOVA). Differences at p < 0.05 were 
considered significant (Sodagar et al., 2013). 
Results 
DPPH scavenging activity of MgOAGANPs
 The DPPH assay is based on the reduction 
capacity of DDPH in the presence of antioxidant 
compounds by donating an electron or a hydrogen to 
the free radical. Both MgOr and MgOrGANPs 
showed an antioxidant activity at the concentrations 
of 50, 75, 100, 125, 150, and 200 µg/mL (Figure 1) 
with an IC
50
 of 38.21 and 61.65 (µg/mL) for MgOr-
GANPs and MgOr, respectively.
Figure 1. The DPPH scavenging activity at various 
concentrations of free MgOr and MgOrGANPs.
Nitric oxide (NO) radical scavenging activities of 
MgOrGANPs
 Results showed that the cells treated with 
MgOr and MgOrGANPs exhibited a considerable 
inhibition of NO production as illustrated in Figure 2 
with the hydroxyl radical scavenging activity of , 
Figure 4. ACE inhibition (%) for free MgOr and 
MgOrGANPs at various concentrations after 30, 60, 
and 90 minutes exposure time.
Cytotoxicity assay
 The growth inhibition and cytotoxicity of 
MgOr and MgOrGANPs towards human colon 
cancer (HT29), human liver cancer (HepG2), human 
breast cancer (MCF7), and normal breast cancer 
(MCF10a) cell lines were investigated using MTT 
assay. The cells were similarly treated with MgOr 
and MgOrGANPs at various concentrations of 1.56, 
3.12, 6.25, 12.50, 25, 50, and 1000 µg/mL for 72 h. A 
substantial morphological changes appeared in 
HepG2, MCF7, and HT29 cell lines after the treat-
ment of MgOr and MgOrGANPs as shown in Figure 
5., HepG2 appeared to be more sensitive to MgOr 
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and MgOrGANPs with an IC
50
 of 24.97 ± 0.1 and 
12.83 ± 0.2, respectively, while MCF10a was the 
least sensitive with an IC
50
 of 270.74 ± 0.09 and 
302.34 ± 0.15 for MgOr and MgOrGANPs, respec-
tively. Additionally, when compared with MCF10a 
cells, the IC
50
 value of MgOrGANPs was about 20 
times higher than that recorded in HT29 and MCF7 
cells. 
Discussion 
In the present work, the NPs were successfully 
prepared by using GA polymer. The nano-encapsula-
tion of MgOr improved its stability and antioxidant 
properties. The preparation of MgOrGANPs required 
an efficient stabiliser like GA to prevent aggregation 
and control growth. GA is commonly used as both 
stabilising and reducing agents. The purpose of using 
deionised water during the encapsulation of MgOr 
into GANPs was to improve the dispersion of parti-
cles using sonication in order to prepare NPs at the 
desired concentrations (Shi et al., 2011).
 The DPPH assay demonstrated the reaction 
between the free radical and antioxidants. Therefore, 
the electron became pairs and resulted in decreased 
absorption. This test was characterised by the reduc-
tion of DPPH with a colour change from purple to 
colourless or pale yellow. The decolourisation of 
DPPH was quantified based on the variation in the 
absorbance values (Ndhlala et al., 2010). The DPPH 
Figure 5. MgOr and MgOrGANPs effects on the viability of treated cells using MTT assay.
Hassani, A., et al./IFRJ 27(1) : 150 - 159 155
results showed strong radical scavenging activities of 
MgOr and MgOrGANPs. 
 The investigation on radical scavenging 
activities presented excellent correlation between 
MgOr and MgOrGANPs before and after encapsula-
tion into the GA polymer. GA is a high molecular 
weight biopolymer with a variable mixture of glyco-
proteins and polysaccharides. Hence, GA, which 
acted as both coating and reducing agents, increased 
the percentage of oxidation inhibition of NPs. The 
reduced inhibition was attributed to the reduced 
particle surface area available for the scavenging of 
DPPH radicals in the presence of large clusters of 
samples. The rate of absorption recorded at 517 nm 
was influenced by the odd electron of DPPH during 
the coloration process, and it accepted an electron 
donated by the antioxidant compound. MgOrGANPs 
displayed higher active scavenging activity as com-
pared to MgOr due to their capacity to scavenge the 
stable free radical (DPPH) that reacted with the 
hydroxyl groups of GA. The results indicated that the 
encapsulation of MgOr into GANPs improved its 
antioxidant properties. Antioxidant activities of GA 
has been established previously which confirms its 
pharmaceutical applications as a nanocarrier for 
tumour-specific treatment (Gamal el-din et al., 
2003).
 The nitric oxide (NO) assay has major 
importance for several types of inflammatory 
processes. NO, as a gaseous free radical, was respon-
sible for various beneficial biological effects (Dowd-
ing et al., 2012). NO assay is focused on the interac-
tion between oxygen and NO being generated spon-
taneously by sodium nitroprusside in aqueous 
solution at physiological pH. These interactions 
generated nitric ions that could be evaluated using 
Griess’ reagent. 
 The pre-treatment of the cells with MgOr 
and MgOrGANPs at various concentrations inhibited 
the lipopolysaccharide (LPS) stimulation of NO 
accumulation. Furthermore, scavengers compete 
with oxygen in order to decrease the production of 
nitric ions. It has been shown that the production of 
NO is induced by bacterial LPS (Wang and Mazza, 
2002).
 The MgOrGANPs yielded effective inhibi-
tion of NO secretion at concentrations ranging 
between 62.5 and 500 µg/mL under a concentra-
tion-dependent manner. The significant radical scav-
enging activity at 500 µg/mL was related to the 
antioxidant activity of GA. The analysis revealed that 
MgOrGANPs yielded higher inhibitory activity than 
the pure MgOr with an IC
50
 values of 56.9 and 89.56 
µg/mL, respectively (p < 0.05). This findings     
confirm that MgOr protects its antioxidant activity. 
However, the mechanism causing the downregula-
tion of NO using MgOr and MgOrGANPs has not 
been clarified. The potent antioxidant activity of GA 
is linked to the protein fraction of GA that corre-
sponded to 0.76% (w/w) of this coating material. In 
addition, the potent antioxidant activity of GA 
against NO might be related to the groups of amino 
acids tyrosine, methionine, and histidine. It has been 
reported that GA has antioxidant scavenging activi-
ties under specific in vitro conditions by affecting the 
scavenging activity of the resulted NO (Gamal el-din 
et al., 2003). The biopolymer might be linked with 
the interaction between the encapsulated agent and 
NO due its properties as membranes semipermeable 
to oxygen while molecules with similar volume to 
oxygen can penetrate into the nanocarrier, and  
subsequently scavenged by MgOr.
 In general, the antioxidant compounds are 
frequently used in the treatment of various diseases 
due to their scavenging capacities (Vivekananthan et 
al., 2003). Antioxidant is also a potent inhibitor, 
which may explain its important effect in cancer 
treatments and reactive oxygen species (Ranneh et 
al., 2016). Furthermore, various side effects caused 
by the excessive level of NO radical produced 
including toxic effects are observed in specific 
tissues and inflammatory conditions, such as ulcera-
tive colitis, multiple sclerosis, and juvenile diabetes 
mellitus (Mikkelsen and Wardman, 2003). 
 β-carotene is a natural carotenoid deemed as 
a major precursor of vitamin A and has been estab-
lished as a free radical scavenger with potential 
chain-breaking antioxidant activities. It is a powerful 
antioxidant, derived from plants and protects human 
body against the attack of free radicals (Albanes et 
al., 1996; Yusuf et al., 2012). In the biosystem, 
β-carotene tends to convert into retinol due its antiox-
idant properties and can also protect nervous system 
against neurodegenerative disorders (Obulesu et al., 
2011). 
 The principle of β-carotene assay is primari-
ly based on linoleic acid oxidation, which results in a 
decrease of β-carotene’s yellow colour. In the present 
work, the degradation of β-carotene was inhibited by 
the presence of MgOrGANPs as antioxidant. Inter-
estingly, the values of β-carotene antioxidant activity 
were increased in a dose-dependent manner. The 
MgOrGANPs exhibited much higher levels of 
antioxidant activity than MgOr which can be related 
to the functional groups of GA used as nanocarrier. 
The data revealed a link between antioxidant effects 
of MgOr and MgOrGANPs, and its concentration as 
well as the decrease of β-carotene loss in samples.
 The results mentioned a concentration-de-
pendent inhibition of β-carotene, while the concen-
tration of MgOrGANPs of 500 µg/mL and 58.4% of 
antioxidant activity (p < 0.05) appeared to be signifi-
cantly higher than the other concentrations. These 
differences can be explained by the oxygen scaveng-
ing property of β-carotene that influenced the oxygen 
functionalities on MgOrGANPs. The amount and 
types of antioxidant influence the stability of β-caro-
tene. A previous study revealed a slower degradation 
of β-carotene in the presence of GA with higher 
concentration of antioxidants. The main role of 
antioxidant is to protect biosystem against reactive 
oxygen species (ROS) such as hydrogen peroxides 
and hydroxyl radicals (Castro et al., 2006). Thus, the 
therapeutic effect of NPs may be associated with its 
ability to scavenge free radicals. 
 On that account, the presence of GA in 
MgOrGANPs is protective against the attacks of 
lipoxygenase and free radicals BC5 as well as the 
targeting specificity of the nanocarrier based on the 
effect of asialoglycoprotein receptors. Moreover, GA 
has excellent potential for delivering bioactive agents 
as a selected and target-oriented delivery system 
which functions through receptor mediated endocy-
tose (RME) (Banerjee and Chen, 2009). Hence, this 
suggests that GA improves the antioxidant activities 
of MgOr during the encapsulation process. 
 The present work was the first to perform an 
evaluation of ACE inhibitory activity of MgOr by 
loading it to a GA nanocarrier. The measurement of 
ACE-inhibitory percentage based on the absorbance 
measurements at 228 nm exhibited that the percent-
age inhibition of MgOr and MgOrGANPs was 
proportional to the decrease of absorbance recorded. 
Similarly, orotic acid is an anti-hypertensive biomol-
ecule used as an intermediate in pyrimidine synthe-
sis. ACE inhibitors are commonly prescribed to treat 
high blood pressure. The ACE inhibitory effects of 
MgOrGANPs was evaluated and measured as 
ACE-inhibitory percentage using the study samples. 
The effects of MgOr and MgOrGANPs on ACE are 
depicted in Figure 4. There was a slight increase in 
ACE of MgOrGANPs after 90 min as compared to 
the measurements at 30 and 60 min. After the incuba-
tion of 100 µL MgOrGANPs (5 µg/mL) with ACE, 
the results revealed that 41.26, 52.34, and 61.45% in 
ACE were recorded after 30, 60, and 90 min, respec-
tively (p < 0.05). MgOrGANPs were demonstrated to 
have more potent ACE inhibition activity as com-
pared to MgOr. This could be explained by the high 
amount of MgOr released from the GA NPs. Hence, 
it is suggested that GA could improve the antihyper-
tensive capacity of MgOrGANPs. Nonetheless, 
further research is required to validate the findings. 
As a highly heterogeneous compound, GA is incor-
porated with approximately 2% of polypeptide, 
which is an active substance that improves the 
antihypertensive effect.
 The role of GA NPs in biomedical applica-
tions can be related to their unique properties, 
particularly in drug delivery system which confirms 
their high stability and low toxicity (Castro et al., 
2006). In vitro cytotoxicity tests can be used to 
screen biocompounds before testing it in vivo (Kong 
et al., 2014). As shown in Figure 5 , HT29, HepG2, 
and MCF7 cells responded differently against MgOr-
GANPs in exposure media. After 72 h, MCF10a 
showed the highest resistance to the NPs, and HepG2 
appeared to be more sensitive to MgOrGANPs than 
MCF7 and HT29. The purpose of using MCF10a as a 
normal cell lines is to compare the cytotoxicity effect 
of MgOrGANPs towards MCF7 cell lines which can 
be considered as an important requirement in the case 
of formulated drugs. In previous study, biologically 
targeted NPs have been developed to identify differ-
ences between normal Chinese hamster ovary cells 
and MDA-MB231, MCF7, and BT-474 breast cancer 
cells. This is an important consideration in treating 
cancer cells as well as protecting normal cells 
(Al-Qubaisi et al., 2013).
 For HepG2, the lower percentage of cell 
viability was recorded at the concentration of 1,000 
µg/mL of MgOrGANPs, while at the concentration 
of 15.63 µg/mL, 53.23% of cell viability was record-
ed. However, the concentration of 1,000 µg/mL of 
MgOr stimulated lower percentage of cell viability 
(13.3%). Furthermore, the concentration of 15.63 
µg/mL showed 86.22% of viable cells as compared 
to the untreated cells (p < 0.05). In a previous study 
by Nishi et al. (2007), the mechanism of GA NPs 
targeted to the liver has been reported based on the 
interactions between asialoglycoprotein receptors 
(ASGRP), the function of receptor-mediated endocy-
tosis (RME), and nanocarriers (Sarika et al., 2015). 
The results mentioned that the anticancer activity of 
MgOr loaded into GA NPs was slightly higher than 
the free MgOr due to the specific properties of GA 
polymer. The IC
50
 values are shown in Table 1. 
Consequently, the identification of the asialoglyco-
protein receptors (ASGRP) using galactose moiety 
on the surface of hepatocytes have increased the 
toxicity of MgOrGANPs. Additionally, GA conju-
gates have been also tested for controlled and 
sustained-release drug delivery system accordingly. 
MgOrGANPs have also exhibited cytotoxicity and 
improved tumour targeting against the HepG2 cells. 
This may be due to the targeting efficacy of the 
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galactose groups of GA. GA NPs have also shown 
increased uptake caused by the malignant liver 
cancer cells (Sarika et al., 2015).   
Conclusion
 The results confirmed the antioxidant and 
antihypertensive properties of MgOrGANPs. MgOr-
GANPs also showed potent antioxidant activity than 
MgOr due the effect of gum arabic polymer. The 
present work demonstrated that MgOrGANPs can be 
considered as a potential candidate compound for the 
evaluation of prevention and treatment of cancers. 
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